Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Quality enhancement research initiative (QERI) in the dyslipidemia management strategy involving ezetimibe with statin in high risk patients who have not achieved recommended LDL [low-density lipoprotein] targets

Trial Profile

Quality enhancement research initiative (QERI) in the dyslipidemia management strategy involving ezetimibe with statin in high risk patients who have not achieved recommended LDL [low-density lipoprotein] targets

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 May 2008

At a glance

  • Drugs Ezetimibe; HMG-CoA reductase inhibitors
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms GUIDE
  • Most Recent Events

    • 13 May 2008 Status changed from in progress to completed on clinicaltrials.gov
    • 31 Oct 2007 Status changed from recruiting to in progress.
    • 14 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top